Back to Search Start Over

EWSR1-SMAD3 -Positive Fibroblastic Tumor.

Authors :
Foot O
Hallin M
Jones RL
Sumathi VP
Thway K
Source :
International journal of surgical pathology [Int J Surg Pathol] 2021 Apr; Vol. 29 (2), pp. 179-181. Date of Electronic Publication: 2020 Jul 03.
Publication Year :
2021

Abstract

EWSR1-SMAD3 -positive fibroblastic tumor is a recently characterized neoplasm with distinct clinicopathologic features and recurrent EWSR1-SMAD3 gene fusion. ESFT typically presents as a small, painless tumor in extremity subcutaneous tissues. Their behavior is benign, although they are prone to local recurrence. They typically comprise two components: intersecting fascicles of overlapping, uniform plump spindle cells, and less cellular hyalinized areas containing stippled calcifications. Immunohistochemically, the cells consistently show diffuse ERG nuclear expression, while other markers are negative. The morphology of this neoplasm can lead to histologic confusion with both benign and malignant soft tissue tumors, including monophasic synovial sarcoma, malignant peripheral nerve sheath tumor, and spindle cell sarcoma, not otherwise specified. Correct identification of ESFT is critical, most importantly to avoid unnecessary overtreatment as sarcoma.

Details

Language :
English
ISSN :
1940-2465
Volume :
29
Issue :
2
Database :
MEDLINE
Journal :
International journal of surgical pathology
Publication Type :
Academic Journal
Accession number :
32615834
Full Text :
https://doi.org/10.1177/1066896920938124